UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
G1L6E5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
D2HL83 | Peptidylglycine alpha-amidating monooxygenase (Fragment) |
|
1 | 0 |
|
A0A7N5P8W0 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
G1L6I6 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7N5P8E8 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
D2HAP5 | Paraoxonase (Fragment) |
|
3 | 0 |
|
D2HK57 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
D2H9S9 | L-selectin (Fragment) |
|
3 | 0 |
|
A0A7N5KLV9 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
G1LBT4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
Q6LCI5 | Neurotrophic factor BDNF precursor form |
|
1 | 0 |
|
Q8WN20 | Glycoprotein hormones alpha chain |
|
2 | 0 |
|
A0A7N5KJC5 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
D2HTH5 | Potassium channel domain-containing protein (Fragment) |
|
1 | 0 |
|
D2HPZ7 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
G1MFX7 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
3 | 0 |
|
A0A7N5P387 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A7N5JZY2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
G1LUM0 | Paraoxonase |
|
3 | 0 |
|
A0A7N5K732 | Hyaluronidase |
|
1 | 0 |
|
G1LZM9 | Pannexin |
|
1 | 0 |
|
D2HGN0 | Rhodopsin (Fragment) |
|
2 | 0 |
|
D2GZP0 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
2 | 0 |
|
A0A7N5K3E8 | P2X purinoceptor |
|
1 | 0 |
|
A0A7N5JCY7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025